Human Investing’s DexCom DXCM Stock Holding History

Human Investing’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-192	Closed	-$17K	–	159
2021 Q1	$17K	Hold	192	–	–	﹤0.01%	203
2020 Q4	$18K	Hold	192	–	–	0.01%	202
2020 Q3	$20K	Hold	192	–	–	0.01%	195
2020 Q2	$19K	Sell	192 -1,180	-86%	-$106K	0.01%	191
2020 Q1	$92K	Buy	1,372 +1,180	+615%	+$73.4K	0.04%	118
2019 Q4	$10K	Hold	192	–	–	﹤0.01%	282
2019 Q3	$7K	Hold	192	–	–	﹤0.01%	289
2019 Q2	$7K	Hold	192	–	–	﹤0.01%	289
2019 Q1	$6K	Hold	192	–	–	﹤0.01%	277
2018 Q4	$6K	Buy	+192	New	+$6.09K	﹤0.01%	295

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Human Investing's DXCM Position: Q2 2021 in Review

Human Investing sold out of DexCom (DXCM) in Q2 2021, closing a stake of 192 shares — an estimated $17K sold.

Human Investing first reported a position in DXCM in Q4 2018 and held it in 10 quarters. The position peaked at $92K in Q1 2020. 728 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

Human Investing reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
Human Investing sold 192 DexCom shares in Q2 2021, an estimated $17K.
Human Investing first reported a position in DexCom in Q4 2018 and held it in 10 quarters.
Human Investing's DexCom position peaked at $92K in Q1 2020.
728 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on Human Investing's 13F filing for Q2 2021, filed 2 Aug 2021.